Status:
COMPLETED
High-Sensitivity Troponin in the Evaluation of Patients With Acute Coronary Syndrome
Lead Sponsor:
University of Edinburgh
Collaborating Sponsors:
NHS Lothian
NHS Greater Glasgow and Clyde
Conditions:
Acute Coronary Syndrome
Myocardial Infarction
Eligibility:
All Genders
Phase:
NA
Brief Summary
In patients with chest pain the diagnosis of a heart attack (myocardial infarction) is made where there is evidence of heart muscle damage using a blood test to measure the heart muscle protein tropon...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Suspected acute coronary syndrome
- Troponin I measurement as part of routine clinical care
- Exclusion criteria:
- \- None
Exclusion
Key Trial Info
Start Date :
June 10 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 3 2017
Estimated Enrollment :
48282 Patients enrolled
Trial Details
Trial ID
NCT01852123
Start Date
June 10 2013
End Date
March 3 2017
Last Update
June 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Infirmary of Edinburgh
Edinburgh, Lothian, United Kingdom, EH16 4SB